Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:961-968
Published online before print March 19, 2009, doi: 10.1161/CIRCRESAHA.108.190280
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/8/961    most recent
CIRCRESAHA.108.190280v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sultan, A.
Right arrow Articles by Hansson, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sultan, A.
Right arrow Articles by Hansson, G. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
Related Collections
Right arrow Animal models of human disease
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrowRelated Article
(Circulation Research. 2009;104:961.)
© 2009 American Heart Association, Inc.


Molecular Medicine

T Cell–Mediated Inflammation in Adipose Tissue Does Not Cause Insulin Resistance in Hyperlipidemic Mice

Ariane Sultan, Daniela Strodthoff, Anna-Karin Robertson, Gabrielle Paulsson-Berne, Jeremy Fauconnier, Paolo Parini, Mikael Rydén, Nicolas Thierry-Mieg, Maria E. Johansson, Alexander V. Chibalin, Juleen R. Zierath, Peter Arner, Göran K. Hansson

From the Center for Molecular Medicine and Department of Medicine (A.S., D.S., A.-K.R., G.P.B., M.E.J., G.K.H.), Karolinska University Hospital, Stockholm, Sweden; Institut National de la Santé et de la Recherche Médicale (A.S.), ERI 25 and Université de Montpellier 1, Unité de Formation et de Recherche, Médecine, Montpellier, France; Departments of Physiology and Pharmacology (J.F.) and Molecular Medicine and Surgery (A.V.C., J.R.Z.), Karolinska Institutet, Stockholm, Sweden; Departments Laboratory Medicine (P.P.) and Medicine (M.R., P.A.), Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden; and Laboratoire Techniques de l’Ingénierie Médicale et de la Complexité–Informatique, Mathématiques et Applications de Grenoble (N.T.-M.), Faculte de Medecine, La Tronche, France.

Correspondence to Dr Goran K. Hansson, Center for Molecular Medicine L8:03, Karolinska University Hospital, SE-17176 Stockholm, Sweden. E-mail Goran.Hansson{at}ki.se

Obesity is associated with chronic inflammation in adipose tissue. Proinflammatory cytokines including tumor necrosis factor-{alpha} and interleukin-6 secreted by adipose tissue during the metabolic syndrome are proposed to cause local and general insulin resistance and promote development of type 2 diabetes. We have used a compound mutant mouse, Apoe–/–xCD4dnTGFbR, with dysregulation of T-cell activation, excessive production of proinflammatory cytokines, hyperlipidemia, and atherosclerosis, to dissect the role of inflammation in adipose tissue metabolism. These mice are lean, which avoids confounding effects of concomitant obesity. Expression and secretion of a set of proinflammatory factors including tumor necrosis factor-{alpha}, interferon-{gamma}, and monocyte chemoattractant protein-1 was increased in adipose tissue of Apoe–/–xCD4dnTGFbR mice, as was the enzyme 11β-hydroxysteroid dehydrogenase type 1, which converts cortisone to bioactive cortisol. Interleukin-6, which has an inhibitory glucocorticoid response element in its promoter, was not upregulated. In spite of intense local inflammation, insulin sensitivity was not impaired in adipose tissue of Apoe–/–xCD4dnTGFbR mice unless exogenous interleukin-6 was administered. In conclusion, T-cell activation causes inflammation in adipose tissue but does not lead to insulin resistance in this tissue in the absence of interleukin-6.


Key Words: adipose tissue • cytokines • inflammation • insulin resistance • interleukin-6 • T cells


Related Article:

A Dual Role of CD4+ T Cells in Adipose Tissue?
Christian M. Matter and M. A. Sokrates Stein
Circ. Res. 2009 104: 928-930. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
H. Wu and C. M. Ballantyne
Inflammation, Adipose Tissue, and T Cells: What Is the "Straight Skinny" on Lean Versus Fat Mice?
Circ. Res., July 17, 2009; 105(2): e3 - e4.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Sultan and G. K. Hansson
Response to the Letter by Wu and Ballantyne
Circ. Res., July 17, 2009; 105(2): e5 - e5.
[Full Text] [PDF]


Home page
Circ. Res.Home page
C. M. Matter and M. A. S. Stein
A Dual Role of CD4+ T Cells in Adipose Tissue?
Circ. Res., April 24, 2009; 104(8): 928 - 930.
[Full Text] [PDF]